"Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study."

Originally aired on Tuesday, September 17th, 2019, from 2:00 PM ET to 3:00 PM ET • Hosted by the Pediatric Community of Practice (PCOP)

"Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study."
(Am J Transplant. 2019 Jun 19. doi: 10.1111/ajt.15505.)

In this article:
[After following] 61 pediatric lung transplant recipients for 2+ years or until they met a composite primary endpoint including bronchiolitis obliterans syndrome/obliterative bronchiolitis, retransplant, or death..., findings raise the possibility that the immunologic impact of CARV following pediatric lung transplant is different than that observed in adults.

Speaker:
Stuart Sweet, MD, PhD • Washington University in St. Louis, St. Louis, MO

Moderator:
Lara Danziger-Isakov, MD, MPH • Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Watch Video

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.